Cargando…
Ulinastatin treatment and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass. A note of aution
Autor principal: | Lema, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Anesthesiologists
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558661/ https://www.ncbi.nlm.nih.gov/pubmed/23372897 http://dx.doi.org/10.4097/kjae.2013.64.1.91 |
Ejemplares similares
-
Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass
por: Oh, Se-young, et al.
Publicado: (2012) -
High-dose ulinastatin improves postoperative oxygenation in patients undergoing aortic valve surgery with cardiopulmonary bypass: A retrospective study
por: Rhee, Ka-Young, et al.
Publicado: (2018) -
Effects of Ulinastatin on Postoperative Blood Loss and Hemostasis in Atrioventricular Valve Surgery with Cardiopulmonary Bypass
por: Park, Jae Bum, et al.
Publicado: (2013) -
Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass
por: Wang, Hai, et al.
Publicado: (2022) -
Retracted: Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)